148 related articles for article (PubMed ID: 34861571)
41. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496
[TBL] [Abstract][Full Text] [Related]
42. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
[TBL] [Abstract][Full Text] [Related]
43. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J
J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355
[TBL] [Abstract][Full Text] [Related]
44. US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011-2015.
Peterson C; Xu L; Mikosz CA; Florence C; Mack KA
J Subst Abuse Treat; 2018 Sep; 92():35-39. PubMed ID: 30032942
[TBL] [Abstract][Full Text] [Related]
45. Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder.
Andraka-Christou B
Health Aff (Millwood); 2021 Jun; 40(6):920-927. PubMed ID: 34097509
[TBL] [Abstract][Full Text] [Related]
46. Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021.
Clemans-Cope L; Lynch V; Payton M; Aarons J
Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):49. PubMed ID: 35794626
[TBL] [Abstract][Full Text] [Related]
47. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
[TBL] [Abstract][Full Text] [Related]
48. Emergency department presentation of opioid use disorder and alcohol use disorder.
Xierali IM; Day PG; Kleinschmidt KC; Strenth C; Schneider FD; Kale NJ
J Subst Abuse Treat; 2021 Aug; 127():108343. PubMed ID: 34134862
[TBL] [Abstract][Full Text] [Related]
49. The phenomics and genetics of addictive and affective comorbidity in opioid use disorder.
Freda PJ; Moore JH; Kranzler HR
Drug Alcohol Depend; 2021 Apr; 221():108602. PubMed ID: 33652377
[TBL] [Abstract][Full Text] [Related]
50. Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon.
Springer R; Marino M; Bailey SR; Angier H; O'Malley JP; Hoopes M; Lindner S; DeVoe JE; Huguet N
Addiction; 2019 Oct; 114(10):1775-1784. PubMed ID: 31106483
[TBL] [Abstract][Full Text] [Related]
51. Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County.
Beachler T; Zeller TA; Heo M; Lanzillotta-Rangeley J; Litwin AH
J Rural Health; 2021 Jan; 37(1):29-34. PubMed ID: 32738095
[TBL] [Abstract][Full Text] [Related]
52. Social Stigma toward Persons with Opioid Use Disorder: Results from a Nationally Representative Survey of U.S. Adults.
Taylor BG; Lamuda PA; Flanagan E; Watts E; Pollack H; Schneider J
Subst Use Misuse; 2021; 56(12):1752-1764. PubMed ID: 34315335
[No Abstract] [Full Text] [Related]
53. National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness.
Han BH; Doran KM; Krawczyk N
J Subst Abuse Treat; 2022 Jan; 132():108504. PubMed ID: 34102461
[TBL] [Abstract][Full Text] [Related]
54. Opioid Use Disorder and Overdose in Older Adults With Breast, Colorectal, or Prostate Cancer.
Roberts AW; Eiffert S; Wulff-Burchfield EM; Dusetzina SB; Check DK
J Natl Cancer Inst; 2021 Apr; 113(4):425-433. PubMed ID: 32805032
[TBL] [Abstract][Full Text] [Related]
55. Treatment utilization among persons with opioid use disorder in the United States.
Wu LT; Zhu H; Swartz MS
Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
[TBL] [Abstract][Full Text] [Related]
56. Prescription drug monitoring programs: Assessing the association between "best practices" and opioid use in Medicare.
Moyo P; Simoni-Wastila L; Griffin BA; Harrington D; Alexander GC; Palumbo F; Onukwugha E
Health Serv Res; 2019 Oct; 54(5):1045-1054. PubMed ID: 31372990
[TBL] [Abstract][Full Text] [Related]
57. Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health.
Sugarman OK; Bachhuber MA; Wennerstrom A; Bruno T; Springgate BF
PLoS One; 2020; 15(1):e0227968. PubMed ID: 31961908
[TBL] [Abstract][Full Text] [Related]
58. Opioid Use Disorder Trends from 2002 to 2017 by Cigarette Smoking Status in the United States.
Parker MA; Weinberger AH
Nicotine Tob Res; 2021 Aug; 23(8):1405-1409. PubMed ID: 32960266
[TBL] [Abstract][Full Text] [Related]
59. Treatment Of Opioid Use Disorder Among Commercially Insured US Adults, 2008-17.
Shen K; Barrette E; Dafny LS
Health Aff (Millwood); 2020 Jun; 39(6):993-1001. PubMed ID: 32479213
[TBL] [Abstract][Full Text] [Related]
60. Differential adoption of opioid agonist treatments in detoxification and outpatient settings.
Dunn KE; Huhn AS; Strain EC
J Subst Abuse Treat; 2019 Dec; 107():24-28. PubMed ID: 31757261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
